quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:57:21·261d
INSIDERFiling
Vigil Neuroscience Inc. logo

Director Budd Haeberlein Samantha L. returned 17,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

VIGL· Vigil Neuroscience Inc.
Health Care
Original source

Companies

  • VIGL
    Vigil Neuroscience Inc.
    Health Care

Recent analyst ratings

  • May 28UpdateStifel$8.00
  • Dec 4UpdateWilliam Blair-
  • Dec 19UpdateMorgan Stanley$4.00
  • Oct 18UpdateJMP Securities$23.00
  • Mar 31UpdateMizuho$15.00
  • Sep 16UpdateWedbush$19.00

Related

  • SEC251d
    SEC Form 15-12G filed by Vigil Neuroscience Inc.
  • SEC252d
    Amendment: SEC Form SCHEDULE 13G/A filed by Vigil Neuroscience Inc.
  • SEC252d
    Amendment: SEC Form SCHEDULE 13G/A filed by Vigil Neuroscience Inc.
  • SEC259d
    SEC Form EFFECT filed by Vigil Neuroscience Inc.
  • SEC259d
    SEC Form EFFECT filed by Vigil Neuroscience Inc.
  • SEC259d
    Amendment: SEC Form SCHEDULE 13D/A filed by Vigil Neuroscience Inc.
  • INSIDER259d
    Large owner Atlas Venture Fund Xii, L.P. returned 5,836,874 shares to the company (SEC Form 4)
  • SEC261d
    SEC Form S-8 POS filed by Vigil Neuroscience Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022